Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-07-01

Clinical Trial Update: Effect of Tezepelumab on Barrier Function in Severe Asthmatic Patients With and Without Comorbid Chronic Rhinosinusitis With Nasal Polyps [NA]

View source ↗

Summary

This clinical trial update evaluates tezepelumab’s effect on barrier function in severe asthma patients, with and without chronic rhinosinusitis with nasal poly…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tezepelumab (tezepelumab)

Snippet

Sponsor: Medical University of Vienna | Conditions: Asthma Bronchiale, Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) | NA | Status: NOT_YET_RECRUITING